Company Active LTD

Company profile

Designworks Windsor Limited

Designworks | Award-winning rapid product design and manufacturing business

Award-winning industrial product design & engineering consultancy. Experience creating innovative products, building meaningful brands, and bringing game-changing experiences to life.

CRN
04360898
Founded
2002
Age
24

Overview

Legal name
DESIGNWORKS WINDSOR LIMITED
Region
South East England
Registered address
UNIT 2, WINDSOR BUSINESS CENTRE
VANSITTART ESTATE
WINDSOR
BERKSHIRE
ENGLAND
SL4 1SP
Insolvency history
No

Company events

Reference milestones and recent Companies House filing stream events.

6 events
08 Feb
2027

Confirmation statement due

Confirmation Due

Next confirmation statement due date

31 Oct
2026

Accounts due

Accounts Due

Next accounts due date

10 Jun
2026

Accounts With Accounts Type Total Exemption Full

Accounts Analysed

AA | Transaction MzUyNjI0MzQyOGFkaXF6a2N4

Published 10 Jun 2026 17:30

25 Jan
2026

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Jan
2025

Accounts filed

Accounts

Last accounts made up date

25 Jan
2002

Incorporated

Inception

Company registered at Companies House

Public funding

2 awards
First funded
2014
Funded years
2014, 2017
Age at first award
12 years

Projects

2017 Feasibility Studies

Novel inflatable leg support for the prevention of wound ulcers

1 Aug 2017 to 31 Jul 2018

Awarded
£34,665
Total cost £49,522

The main aim of this project is to reduce the incidence of venous leg ulcers, and in particular to reduce or remove the risk of any recurrence, by introducing a novel, easy-to-fit inflatable pressure gaiter. By radically improving ease of use, it is predicted that patient compliance in using a pressure support mechanism will rise significantly, especially...

2014 Collaborative R&D

Phase-insensitive Ultrasonic Computed Tomography (piUCT) for the diagnosis of breast disease

1 Feb 2014 to 31 Jul 2017

Awarded
£29,310
Total cost £48,850

Annually, 49,500 UK women are diagnosed with breast cancer. However, 92,000 unnecessary biopsies are performed as only about 30% of suspicious lesions are found to be malignant. As each suspicious lesion must be confirmed by biopsy, better diagnosis would avoid unnecessary biopsy procedures, improve care and reduce cost to the NHS. The gold standard of tr...

Product types

Collaborative R&D Feasibility Studies